Our latest
Creative Biosciences
Creative Biosciences Recognized on the Hurun Future Unicorns: Global Gazelles Index 2025

Recently, the Hurun Research Institute—one of the world’s most influential authorities on global entrepreneurship rankings—released the Hurun Future Unicorns: Global Gazelles Index 2025 in Beijing E-Town. The index identifies 819 high-growth companies fo

Jan 27 , 2026
Media Coverage
Authoritative media releases


Press releases
Colosafe® Showcased in the National "13th Five-Year" Scientific and Technical Innovation Achievement Exhibition
Nov 02 , 2021
Marvelous News! Creative Biosciences Won the National-Level Title of "Little Giant" Enterprise in the Category of Specialization, Refinement, Differentiation, and Innovation.
Sep 07 , 2024
Colosafe® Gains Market Entry in Brazil--Groundbreaking in South America!
Sep 04 , 2024
Broadening Global Expansion: CreativeBio Draws Attention at ADLM 2024
May 27 , 2024
CreativeBio Revealed Over 170,000 Prospective Clinical Application Data of Colosafe®
Jun 06 , 2022
Creative Biosciences & Cooper Biosciences MENA Announce Partnership for the Commercialization of Colosafe® in the MENA region
Nov 23 , 2022
CreativeBio Major Announcement: Over 830,000 Real-World Application Test Cases of Colosafe® Released
May 27 , 2024
Creative Biosciences (Hong Kong) Co., Ltd Has Been Established - Rooted in the Greater Bay Area, Oriented Towards The Global Market.
Mar 07 , 2023
The Annual Gala and All-Staff Meeting Has Successfully Concluded: United in Strength, Let the Dragon Soaring Across the Five Continents
Dec 26 , 2023
Creative Biosciences (Guangzhou) and DKSH Enters into a Strategic Partnership to Lead Reducing Cancer Burden in Asia
Apr 23 , 2021
Clinical Utility of Colosafe®Is Once Again Proved Valuable!
Mar 17 , 2021
Top 100! Creative Biosciences Was Named "The First Guangzhou’s Top 100 Emerging Enterprises"
Dec 27 , 2023